PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 96 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $8,000 | -42.9% | 2,190 | -60.1% | 0.00% | – |
| Q1 2021 | $14,000 | -12.5% | 5,490 | -11.7% | 0.00% | – |
| Q4 2020 | $16,000 | +23.1% | 6,215 | 0.0% | 0.00% | – |
| Q3 2020 | $13,000 | -45.8% | 6,215 | -19.9% | 0.00% | – |
| Q2 2020 | $24,000 | +50.0% | 7,757 | +0.2% | 0.00% | – |
| Q1 2020 | $16,000 | -54.3% | 7,740 | -19.0% | 0.00% | – |
| Q4 2019 | $35,000 | +34.6% | 9,553 | +23.5% | 0.00% | – |
| Q3 2019 | $26,000 | -23.5% | 7,734 | 0.0% | 0.00% | – |
| Q2 2019 | $34,000 | +30.8% | 7,734 | 0.0% | 0.00% | – |
| Q1 2019 | $26,000 | +23.8% | 7,734 | 0.0% | 0.00% | – |
| Q4 2018 | $21,000 | -51.2% | 7,734 | 0.0% | 0.00% | – |
| Q3 2018 | $43,000 | +10.3% | 7,734 | 0.0% | 0.00% | – |
| Q2 2018 | $39,000 | -13.3% | 7,734 | +17.9% | 0.00% | – |
| Q1 2018 | $45,000 | -10.0% | 6,560 | 0.0% | 0.00% | – |
| Q4 2017 | $50,000 | +72.4% | 6,560 | +28.7% | 0.00% | – |
| Q3 2017 | $29,000 | +11.5% | 5,097 | 0.0% | 0.00% | – |
| Q2 2017 | $26,000 | – | 5,097 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 778,230 | $5,308,000 | 5.22% |
| BVF INC/IL | 3,592,549 | $24,501,000 | 2.48% |
| Prosight Management, LP | 563,763 | $3,845,000 | 2.41% |
| SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $5,456,000 | 0.83% |
| Virtus ETF Advisers LLC | 125,695 | $857,000 | 0.74% |
| EAM Investors, LLC | 521,460 | $3,556,000 | 0.59% |
| Tekla Capital Management LLC | 2,087,380 | $14,236,000 | 0.55% |
| Orbimed Advisors | 5,550,000 | $37,851,000 | 0.47% |
| EAM Global Investors LLC | 125,635 | $857,000 | 0.44% |
| Schonfeld Strategic Advisors LLC | 830,637 | $5,665,000 | 0.42% |